Aridol

Aridol (Mannitol) is an inhalation powder used for bronchial challenge testing. Learn about its uses, effects, and precautions here.

Aridol (Mannitol) is primarily used as a diagnostic tool in bronchial challenge testing. This test helps assess airway hyperresponsiveness, which can be indicative of conditions like asthma. By inhaling Mannitol, healthcare professionals can observe how the airways react, providing insights into respiratory health. Aridol is not intended for therapeutic use but rather for diagnostic purposes.

When inhaled, Aridol (Mannitol) can cause temporary airway constriction, which is monitored during the bronchial challenge test. This effect helps determine the sensitivity of the airways. Common effects may include coughing or shortness of breath, which are typically managed under medical supervision during the test.

Aridol (Mannitol) should be used strictly under medical supervision. Individuals with severe respiratory conditions should exercise caution. It is important to follow the healthcare provider's instructions carefully to ensure safe and accurate testing. Always inform your healthcare provider of any existing respiratory conditions or allergies before using Aridol.

Aridol (Mannitol) may interact with other respiratory medications. It is important to inform your healthcare provider about all medications you are taking before undergoing a bronchial challenge test with Aridol. This includes any inhalers, bronchodilators, or other respiratory treatments.